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A breakdown of the blood-brain barrier occurred in 
mice inoculated intracerebrally (i.c.) or intraperito- 
neally (i.p.) with dengue virus type 2 (DEN2). This 
resulted in leakage of protein-bound Evans blue dye 
and 51Cr-labelled erythrocytes into the brain tissue. 
The leakage increased with time after infection and 
coincided with an increase of a DEN2-induced cyto- 
kine, the cytotoxic factor (CF), in the spleens of such 
mice. The titres of virus in the brain increased 
exponentially in i.c. inoculated mice but the virus was 
not detected in brains of mice given DEN2 by the i.p. 
route. Similar breakdown of the blood-brain barrier 
also occurred in mice inoculated intravenously with 
CF; the damage was dose-dependent and the vascular 
integrity was restored during the 3 h period after 
inoculation. Treatment of mice with antihistamine 
drugs, blocking H1 or H2 receptors, decreased the 
DEN2-induced protein leakage by up to 50% in i.c. 
inoculated mice and up to 92 % in those inoculated i.p. 
Indomethacin, a prostaglandin synthetase inhibitor, 
had no effect. In i.c. inoculated mice protein leakage 
was inhibited by about 60% by treatment with CF- 
specific (CFA) or DEN2-specific antisera (DEN2A) 
whereas protection was complete with the combined 
treatment with both antisera. On the other hand, in i.p. 
inoculated mice the inhibition of protein leakage was 
80 to 89% with CFA. These findings show a 
breakdown of the blood-brain barrier leading to 
cerebral oedema during DEN2 infection which is 
mediated via the release of histamine by a virus-induced 
cytokine. 
Introduction 
Dengue viruses (DEN) generally cause a benign syn- 
drome, dengue fever (DF), which is characterized by the 
acute onset ofsevere headache, myalgia nd fever lasting 
for 3 to 7 days and a maculopapular rash appearing 
towards the end of the illness. The virus also produces a
severe syndrome, dengue haemorrhagic fever/dengue 
shock syndrome (DHF/DSS), which is characterized by 
increased vascular permeability and abnormal haemos- 
tasis (Halstead, 1980, 1988). Extensive biochemical 
changes occur in the enzymes and metabolites ofskeletal 
muscles during DEN infection of mice which may 
explain the origin of myalgia (Agrawal et al., 1978). 
Halstead (1980) put forward a hypothesis that a vascular 
permeability factor is produced in cases of DHF/DSS. 
Indeed, we know now that the vascular permeability is
increased by two cytokines produced during DEN 
infection of mice: a T lymphocyte product, the cytotoxic 
factor (CF) and a macrophage cytotoxin (CF2). Both CF 
and CF2 kill macrophages and T helper cells by a Ca 2+- 
dependent mechanism and increase vascular per- 
meability by the release of histamine (Chaturvedi et al., 
1980; Khanna et al., 1988, 1990, 1991; Dhawan et al., 
1990a, b, 1991). 
During epidemics of dengue, cases of encephalitis 
have been observed. Two such cases have been reported 
from this country (Sarkar et al., 1969; Myers et al., 1969) 
and others from Burma and Indonesia (reviewed by 
Sumarmo et al., 1981): But from none of these cases could 
DEN be isolated from the brain tissue or cerebrospinal 
fluid (CSF); the virus was isolated only from the 
peripheral blood. DEN has been shown to lack the 
ability to invade the central nervous ystem (CNS) from 
the periphery (reviewed by Nathanson & Cole, 1970). 
Despite this, DF/DHF/DSS is characterized by severe 
frontal or retro-orbital headache, hallucination and 
depression, which indicates CNS involvement (Schle- 
singer, 1981). There are reports of definite development 
of cerebral oedema in such cases (S. B. Halstead in 
review by Sumarmo et al., 1981). The cerebral oedema 
can be caused byvasogenic, cytotoxic or hydrocephalic 
mechanisms. In the present study, an effort was made to 
study the integrity of the blood-brain barrier during 
DEN infection of mice. It was observed that the blood- 
brain barrier suffered reversible damage caused by a 
virus-induced cytokine. 
Methods 
Mice. The study was carried out on inbred Swiss albino mice aged 3 
to 4 months, obtained from the mouse colony maintained in this 
Department. 
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Virus. DEN type 2 (DEN2), strain P23085, was used in the form of an 
infected adult mouse brain suspension. The titre of the virus was 
estimated in the brain tissue of mice at different periods after 
inoculation of DEN2 intracerebrally (i.c.). A 10-fold serial dilution of 
each specimen was inoculated i.c. into groups of adult mice (at least 
six), and the titre was calculated by the method of Reed & Muench 
(1938). The titres have been expressed as loglo LDs0 per 30 ktl of the 
brain suspension. The virus was inoculated in doses of 1000 LDs0. 
Normal mouse brain suspension (NMB) was prepared similarly for 
control groups. 
Chemicals. The chemicals and reagents used in the study were Evans 
blue dye (Loba-Chemic Indo-austranal Co.), [slCr]chromium as 
sodium chromate (Bhabha Atomic Research Centre), and indometha- 
cin (Sigma). 
Preparation and assay of cytotoxic factor (CF). CF was prepared from 
the spleen cells of DEN2-infected moribund mice (Charurvedi et al., 
1980) and was purified with a Pharmacia low pressure liquid 
chromatography s stem using a Sephacryl S-200 gel column. The 
amount of protein was estimated by the technique of Lowry et al. 
(1951). Normal mouse spleen homogenate (NH) was similarly prepared 
and used as a control. CF was concentrated byfreeze-drying orby use 
of the Speed Vac (Savant Instrument). The cytotoxic activity of CF was 
assayed using a single-cell suspension of normal mouse spleen cells as 
the target. Doubling dilutions of CF were mixed in equal volumes with 
2 x 106 target cells and incubated at 4 °C for 1 h (Chaturvedi et aL, 
1980; Khanna et al., 1989). The percentage of non-viable cells was 
calculated using the trypan blue dye exclusion method. 
Preparation of antisera against CF. CF-specific antiserum (CFA) was 
prepared in rabbits as described elsewhere (Khanna et al., 1990). CFA 
specifically neutralizes the cytotoxic activity of CF and reacts with it in 
a Western blot (Khanna et al., 1990; M. Khanna & U. C. Chaturvedi, 
unpublished results). Sera obtained from normal rabbits were used as a 
control. 
Preparation of antisera against DEN2. DEN2-specific antisera 
(DEN2A) were prepared by hyperimmunization f mice. A freshly 
prepared brain suspension (20~) from DEN2-infected mice was 
injected i.p. (0.2 ml) at weekly intervals for 5 weeks. DEN2A thus 
prepared was assayed for its capacity to neutralize the virus. Sera 
collected from normal mice were used as a control. 
Assay of blood-brain barrier permeability. Permeability of the blood- 
brain barrier esults in leakage of fluids, protein and cells into the brain 
substance. In the present study leakage of protein was assayed by 
measuring release of plasma protein-bound Evans blue dye into the 
brain whereas the leakage of cells was assayed using radiolabelled 
erythrocytes. 
Evans blue dye method. Mice were inoculated intravenously (i.v.) with 
200 ~tl of a 2~ solution of Evans blue dye dissolved in normal saline 
(0.85~ sodium chloride). After 1 h the mice were anaesthetized with 
halothene i.p. and the brain was perfused with 5 ml normal saline 
through the left cardiac ventricle (Thumwood et al., 1988). A 10~ 
homogenate of the brain was prepared in normal saline and centrifuged 
at 4 °C at 6000 g for 15 rain. The clear supernatant was collected and its 
absorbance was determined at590 nm for the detection of Evans blue. 
The protein content of the fluid was calculated from a standard curve 
obtained with various concentrations of Evans blue coupled to bovine 
serum albumin estimated by the method of Lowry et al. (1951), and 
expressed as ~tg protein/ml (Dhawan et al., 1990a; Khanna et al., 1990). 
The results were expressed as the permeability index (PI) of the blood- 
brain barrier which was calculated by comparison with the values 
obtained in control mice inoculated with NMB, after deducting 
background value, as follows: PI=[100 x (protein in mice given 
DEN2-  background value)/(protein in NMB-inoculated control 
mice - background value)] - 100. 
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Fig. 1. Virus titres in the brain tissue of DEN2-infected mice on 
different days after i.c. (0) or i.p. CA) inoculation. Each point 
represents mean + S.D. from three mice. 
Radioisotope methods. In the second method, movement of radio- 
labelled mouse erythrocytes (MRBC) across the blood-brain barrier 
into the brain substance was monitored. Freshly collected MRBC were 
washed three times with phosphate-buffered saline (PBS) pH 7.2. The 
cells were counted and 3 x 109 MRBC/ml were incubated with 51Cr (1 
mCi/ml as sodium chromate) for 30 min at 37 °C, with intermittent 
shaking. The cells were washed thoroughly with PBS, the cell count was 
adjusted and 100 Ixl of the cell suspension was injected into the tail vein 
of mice. One hour later, mice were anaesthetized with halothene and 
the brains were removed after perfusion as described above. The s lCr 
content of the whole brain was determined and the values were 
expressed as c.p.m./brain. 
All the experiments were repeated and the mean + S.D. of the data 
obtained from eight to 12 mice are presented. 
Results 
Virus titre in the brain o f  mice 
Fo l lowing  i.c. inocu lat ion w i th  DEN2,  the mice  ap- 
peared heal thy up to day 5. On  day 6 post - in fect ion (p.i.), 
ruffl ing o f  the fur and arch ing  o f  the back  occurred 
wh ich  was fo l lowed by severe s ickness wi th  paralys is  o f  
l imbs on days 8 and 9. Al l  the mice  d ied by day 11. M ice  
appeared  to be unaf fected after  in t raper i tonea l  (i.p.) 
inoculat ion o f  DEN2.  Three  mice  were ki l led dai ly f rom 
days 1 to 9 after  i.c. inocu lat ion and on a l ternate days 
f rom days 2 to 16 after  i.p. inocu lat ion o f  DEN2 and the i r  
bra ins  and spleens were col lected. The  bra ins  were 
assayed for virus and the spleens for CF .  The  f indings 
presented in Fig. 1 show that  he virus t itres in the bra in  
increased exponent ia l ly ;  the t itre was 5-8 + 0-8 loglo 
LDs0 per  30 ~tl o f  the bra in  suspens ion on day 9 in i.c. 
inocu lated mice.  In  contrast  no virus could be detected  in 
the bra in  tissue in i.p. inocu lated mice.  
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Production of CF in the spleen 
The data presented in Fig. 2 show that in mice inoculated 
i.c. the cytotoxic activity appeared on day 5 and reached 
a peak on day 9 when 52 (+ 4~)  of target cells were killed. 
In mice inoculated i.p. the peak of activity was seen on 
day 10 p.i. 
Effect of DEN2 infection on blood-brain barrier 
Fig. 3 (a) shows a dark (deep blue) coloration of the brain 
tissue following i.c. inoculation of DEN2 due to leakage 
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Fig. 2. CF titres in the spleen of DEN2-infected mice on different days 
after i.c. (0) or i.p. ~ inoculation. Each point represents mean + S.D. 
from three mice. 
of protein-bound Evans blue dye from the capillaries into 
extravascular spaces. In contrast, the brains of uninocu- 
lated mice or the control mice inoculated with NMB 
excluded the dye and did not show any blue colour. A 
bluish tinge was discernible from day 4 p.i. which 
gradually increased in intensity to become uniformly 
deep blue by day 9 p.i. in i.c. inoculated mice. None of 
the brains showed haemorrhagic spots. On the other 
hand, the brains of i.p. inoculated mice had only a bluish 
tinge from days 4 to 14 p.i. 
The PI, assayed by protein dye leakage into the brains 
on different days after DEN2 inoculation is presented in
Fig. 4(a). A sharp increase in PI occurred from day 7 and 
on day 9 it was 105 + 10 in i.c. inoculated mice. On the 
other hand, in i.p. inoculated mice the protein dye 
leakage was maximal on day 10, when the PI was 59 + 8. 
At later periods it declined, being 15 + 3 on day 16 p.i. 
(Fig. 4a). A similar pattern was observed when 
the leakage of radiolabelled MRBC into the brain tissue 
was assayed (Fig. 4b). 
Effect of CF on blood-brain barrier 
Mice inoculated with 250 p.g of CF i.v. were assayed for 
the integrity of the blood-brain barrier at different 
periods using the protein leakage method. The leakage of 
protein in the brain was maximal at 1 h; thereafter it
declined and the integrity of the blood-brain barrier was 
restored after 3 h (Fig. 5). Therefore, in further 
experiments observations were recorded at 1 h after CF 
inoculation. 
(b) 
(a) 
Fig. 3. Dark coloured appearance of brain following leakage of protein-bound Evans blue dye into the brain tissue. (a) Brains from 
DEN2-infected (A) and control (B) mice. (b) Brain from ice inoculated with 250 ~tg (A), 200 lig (B) or 100 lig (C) of CF; brains in the 
lower ow are from the control group. 
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Fig. 4. Breakdown ofblood-brain barrier in DEN2-infected mice. (a) 
Leakage of protein-bound Evans blue dye in brain tissue xpressed as
PI. (b) Leakage of 5~Cr-labelled MRBC in brain tissue expressed a  
c.p.m./brain. Symbols (Q), i.c. inoculated; (Ak), i.p. inoculated; (11), 
control mice inoculated with NMB. Each point represents mean _ S.D. 
from 10 mice. 
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Fig. 6. Breakdown of blood-brain barrier in mice inoculated with 
different doses of CF. (a) Leakage of protein-bound Evans blue dye in 
brain tissue xpressed as the PI. (b) Leakage of 51Cr-labelled MRBC in 
brain tissue expressed as c.p.m./brain. Each point represents 
mean + S.D. from 10 mice. 
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Fig. 5. PI of the brain tissue at different periods following i.v. 
inoculation ofCF as determined by leakage of protein-bound dye. Each 
point represents mean + S.D. from 12 mice. 
Groups of mice were inoculated with different doses of 
CF i.v. and for the controls, NH was inoculated i.v. After 
1 h the integrity of the blood-brain barrier was assayed 
using Evans blue dye or radiolabelled MRBC. The effect 
of CF was dose-dependent as shown by the gross 
appearance of the brains (Fig. 3 b) and after estimating 
the leakage of protein or radiolabelled MRBC in the 
brain tissue (Fig. 6). 
Effect of antihistamine drugs 
DEN2-infected mice were treated with 250 I-tg of avil 
(H-1 receptor blocker) or ranitidine (H-2 receptor 
blocker) i.v. on different days p.i. and the integrity of the 
blood-brain barrier was assayed using Evans blue dye 
after 1 h. The findings presented in Table 1 show that in 
i.c. inoculated mice the decrease in PI after avil 
treatment was 26 to 43 ~ at different days and that with 
ranitidine was 16 to 37~. When DEN2 was inoculated 
i.p. the decrease in PI following treatment with the two 
antihistamine drugs was 57 to 92~. 
In another set of experiments mice infected i.c. with 
DEN2 were treated i.v. with 250 ~tg of either of the drugs 
on days 4 and 8 p.i. and the integrity of the blood-brain 
barrier was assayed on day 9. It was observed that the PI 
was decreased by 49 ~ by treatment with avil and 43 
with ranitidine. The drug treatment had no effect on the 
clinical progression of the disease. 
Effect of treatment with indomethacin 
Cerebral oedema and breakdown of the blood-brain 
barrier has been reported to be mediated by prostaglan- 
dins in certain situations (Mohanty et al., 1980). Mice 
were given 0.3 mg indomethacin i.p. 24 and 2 h before 
DEN2 i.c. or i.p. and then 0.1 mg i.p. at 48 h intervals 
(Shukla & Chaturvedi, 1981). The integrity of the blood- 
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Tab le  1. Effect of treatment with antihistamine drugs on the blood-brain barrier in 
DEN2-infected mice* 
Avil Ranitidine 
Time p.i. Protein Decrease Protein Decrease 
(days) Groups (p.g/ml) in PI (~) (p.g/ml) in PI (~) 
I. DEN2 by i.c. route 
5 DEN2 + drug 665 + 76 38 908 + 89 16 
DEN2 1074 ± 117 0 1074 ± 117 0 
7 DEN2 + drug 733 + 68 26 754 + ~/0 24 
DEN2 990 ± 77 0 990 ± 77 0 
9 DEN2 + drug 952 ± 89 43 1052 ± 35 37 
DEN2 1677 + 302 0 1677 + 302 0 
II. DEN2 by i.p. route 
10 DEN2 + drug 513 ± 60 57 370 ___ 48 69 
DEN2 1193 ± 55 0 1193 ± 55 0 
12 DEN2 + drug 357 + 74 71 98 + 48 92 
DEN2 1232 ± 109 0 1232 ± 109 0 
* Mice inoculated with DEN2 were treated with 250 ~tg of avil or ranitidine i.v. on different days p.i. 
After 1 h, integrity of the blood-brain barrier was assayed using Evans blue dye. For background values 
mice were given the drug only. Each i.c. group consisted of 10 mice and the i.p. group of eight. The data 
have been presented after deducting background values. The decrease in the PI was calculated as 
follows: Decrease in PI (~)=[100- (P ro te in  in mice given DEN2 and the drug-background 
value)/(protein mice given DEN2 - background value)] x 100. 
Tab le  2. Effect of treatment of mice with indomethacin on 
the blood-brain barrier of DEN2-infected mice* 
Protein (Ltg/ml) 
Time p.i. Decrease 
(days) Control Drug-treated in PI (~) 
I. DEN2by i . c .  route 
7 1213 ± 142 1129± 113 7 
9 1725 ± 310 1716 ±281 1 
II. DEN2 by i.p. route 
10 1132 ± 153 1075 ± 96 5 
12 1280 ± 110 1242 ± 132 3 
* Mice were treated with 0-3 mg indomethacin i.p. at 24 and 2 h 
before DEN2 inoculation i.c. or i.p. and then 0.1 mg doses of the drug 
at 48 h intervals. Each i.c. group consisted of 12 and i.p. group of eight 
mice. The integrity of the blood-brain barrier was assayed on the 
different days p.i. See Table 1 footnote for other details. 
brain barrier was assayed on the different days p.i, The 
data presented in Table 2 show that treatment of mice 
with indomethacin had a negligible ffect on the DEN2- 
induced permeability of the blood-brain barrier. 
Effect of treatment with antisera 
The effect of CF-specific antisera (CFA) on the blood- 
brain barrier of mice given DEN2 or CF was investigat- 
ed. Groups of mice inoculated i.v. with 0.2 ml of various 
10-fold dilutions of CFA were treated 24 h later with 200 
~tg of CF i.v. and the integrity of the blood-brain barrier 
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Fig. 7. Decreased PI by pretreatment of mice with specific antisera. 
Mice given CF i.v. were pretreated with CFA (O), or normal rabbit 
sera (O) or DVA (ID). Mice inoculated with DEN2 i.c. were pretreated 
with DVA (A) or normal mouse sera (A). Each point represents 
mean ± S.D. from 10 mice. 
was assayed after 1 h. Similarly, another group of mice 
given CFA were treated 24 h later with DEN2 i.c. and 
the blood-brain barrier was assayed on day 9 p.i. The 
findings presented in Fig. 7 show a dose-dependent 
decrease in the DEN2- or CF-induced leakage of protein 
in the brain. DEN2A had no effect on the CF-induced 
protein leakage. 
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Table 3. Effect of treatment with antisera on the DEN2-induced permeability 
of the blood-brain barrier* 
Decrease in PI (~) 
Timing of antiserum treatment 
24 h before Day 3 p.i. Day 8 p.i. 
Time p.i. 
(day) CFA DEN2A CFA DEN2A CFA DEN2A 
I. DEN2 by i.c. route 
5 5+3 15+4 12+2 17+5 ND t ND 
7 3+2 10+3 28+5 21+3 ND ND 
9 52+6 41+7 48+4 36+6 60+8 65+--5 
II. DEN2 by i.p. route 
10 80+4 32+7 81+9 28+8 84+-9 22+8 
12 89+-8 28+6 85+12 30+-7 87_+10 26+4 
* Mice were treated i.v. with a 10 -1 dilution of either CFA or DEN2A at 24 h before 
inoculation with DEN2 (given i.c. or i.p. route), or at days 3 or 8 p.i. For controls, mice were 
similarly given normal rabbit sera (for the CFA group) or normal mice sera (for the DEN2A 
group) and DEN2. For blank values, mice were given only the antisera. Each i.c. group 
consisted of 10 mice and each i.p. group of 8. The integrity of the blood-brain barrier was 
assayed on different days p.i. The decrease in the PI was calculated as shown in the Table 1 
footnote. 
ND, Not determined. 
Table 4. Effect of combined treatment with CF-specific 
and DEN2-specific antisera on the blood-brain barrier in 
DEN2-infected mice* 
Timing of 
antisera treatment Protein Decrease 
Groups p.i. (day) ~g/ml) in PI (%) 
1 3 68 _+ 20 96 
2 3 and 8 117 +47 93 
Control Nil 1578 + 237 0 
* Mice of Group 1 inoculated i.e. with DEN2 were treated with CF- 
specific and DEN2-specific antisera (0.2 ml each of 10 -1 dilution) i.v. 
on day 3, whereas those of Group 2 were given two doses of the above 
antisera, the first on day 3 and the second on day 8. Each group 
consisted of 10 mice. The integrity of the blood-brain barrier was 
assayed on day 9 after the virus infection. For other details and controls 
please see footnote o Tables 1and 3. 
The effect of  the t iming of  the administrat ion of CFA 
in relation to inoculat ion with DEN2 was investigated. 
Mice inoculated i.c. or i.p. with DEN2 received a 10 -1 
di lut ion of either of the antisera i.v. at 24 h before 
infection, or at day 3 or 8 p.i. The integrity of  the b lood-  
brain barr ier was assayed on the different days p.i. and 
the data are presented in Table 3. It  was observed that 
t reatment  with either of the antisera was most effective 
(the decrease in P I  being up to 65~)  when given on day 8 
of  the i.c. virus infection. Treatment  with CFA had no 
effect on the outcome of  infection, whereas mice treated 
with DEN2 up to day 3 p.i. d id not develop any apparent  
illness or paralysis. In contrast, CFA provided a 
signif icantly higher level of protect ion to the b lood-bra in  
barr ier  in i.p. inoculated mice, the decrease in the PI 
being 80 to 89~ (Table 3). 
In the mice inoculated i.c. with DEN2,  neither CFA 
nor DEN2A could provide full protect ion against 
permeabi l i ty  of  the b lood-bra in  barr ier ;  therefore, mice 
were treated with both the antisera. To one set of  mice 
given DEN2 i.c., a 10 -1 di lut ion of  both CFA and DVA 
were given i.v. (0.2 ml of  each), on day 3 p.i. To the 
second set of  mice, two doses of  both the ant isera were 
given, one on day 3 and the second on day 8 p.i. The 
controls ment ioned in previous exper iments were in- 
cluded with each set. The integrity of  the b lood-bra in  
barr ier  was assayed on day 9 p.i. The data summarized in 
Table 4 show that inhibit ion of  PI  was 96~ when a s ing le  
dose of  the two antisera were given and 93 ~ when two 
doses were given. 
Discussion 
The findings of the present study demonstrate that 
dur ing DEN2 infection of mice, the b lood-bra in  barr ier  
is damaged resulting in leakage of  prote in-bound Evans 
blue dye and radiolabel led MRBC into the bra in  
substance without any evidence of  f rank haemorrhaging.  
Similar damage to the b lood-bra in  barr ier  was also 
produced, in a dose-dependent manner,  by the inocula- 
t ion of  CF.  The severity of  the damage increased with 
t ime p.i., corresponding to the increased product ion of 
CF  in the spleen. The exponent ia l  increase in virus titres 
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in the brain of i.c. inoculated mice and the failure to 
isolate DEN2 from the brains of i.p. inoculated mice is 
supported by previous findings (Chaturvedi et al., 1978). 
Brain capillaries are highly impermeable because their 
endothelium has tightly sealed junctions between indivi- 
dual cells that prevent he exchange of proteins across 
the vessel wall. Increased vascular permeability results in 
vasogenic oedema, principally in the white matter of the 
brain. Increased permeability of the blood-brain barrier 
could be due to damage to capillary endothelial cells or 
due to various vasoactive mediators which open up the 
junctions between cells. The findings of several experi- 
ments indicate that the damage to the blood-brain 
barrier in the present model is not morphological. These 
experiments are for example: the vascular integrity in 
CF-inoculated mice was restored by 3 h, administration 
of antihistamine drugs to DEN2-infected mice inhibited 
leakage of protein within 1 h, and administration ofCF- 
specific antisera protected it. This is supported by a 
number of studies which did not show any evidence of 
injury to vasculature or the presence of the virus antigen 
or virus particles in the endothelial cells during DEN 
infection (Sahaphong etal., 1980; reviewed by Halstead, 
1988). A reversible induction of capillary permeability 
has been reported by administration of DEN2-induced 
CF/CF2 in mice (Khanna et al., 1990; Dhawan et al., 
1990a) which supports the present s udy. 
It has been observed that CF/CF2-induced capillary 
permeability is inhibited by antihistamine drugs in a 
dose-dependent manner, the inhibition being complete 
with a dose of 50 to 250 p.g of the drugs (Khanna et al., 
1990; Dhawan et al., 1990a). However in the present 
study, even after two doses of the drugs, inhibition of 
DEN2-induced permeability was no more than 50~ in 
i.e. inoculated mice, whereas it was up to 92~ in i.p. 
inoculated mice. Treatment of mice with indomethacin, 
an irreversible inhibitor of the enzyme prostaglandin 
synthetase (Vane, 1976), has no effect. Furthermore 
CFA completely protected mice against CF-induced 
increase in capillary permeability, even when the 
antibody was diluted 10 -4 (Khanna et al., 1990). This 
antibody at the 10 -1 dilution produced only a 60~o 
decrease in PI in i.e. inoculated mice, despite the use of 
different schedules. The protection by CFA in i.p. 
inoculated mice was up to89~. Mice given DEN2 by the 
peripheral route failed to show any symptoms because 
the virus does not invade the brain tissue, but a bell- 
shaped curve of CF titres is shown in the present s udy 
(Chaturvedi et al., 1978; Dalakoti et al., 1983). Grau et al. 
(1987) have shown that antibody against tumour necrosis 
factor prevents the development of murine cerebral 
malaria. Therefore, in the latter the presence of oedema, 
haemorrhage and leakage of protein across the blood- 
brain barrier due to cerebrovascular endothelial injury 
may not be due entirely to the parasite itself. This is 
similar to the findings of the present study where CF is 
partly responsible for damage to the blood-brain barrier 
in i.c. infected mice. 
Humoral antibody has been reported to play a critical 
role in recovery from primary DEN infection of mice. 
Adoptive transfer of specific antibody protected 50 to 
100~ of mice against i.e. challenge with DEN (Chatur- 
vedi et al., 1977, 1978). In the present study DEN2A 
protected DEN2-infected mice against sickness and 
paralysis but the effect on the blood-brain barrier was 
partial (65~ protection). Furthermore, this antisera had 
no effect on CF-induced permeability ofthe blood-brain 
barrier. In contrast, the protection was complete when 
i.c. infected mice were treated with both CFA and 
DEN2A. Furthermore, in i.p. inoculated mice (where 
DEN2 does not invade the brain tissue) similar higher 
levels of protection were obtained with CFA. This 
showed that in the present model, the breakdown of the 
blood-brain barrier leading to the cerebral oedema was 
vasogenic and mediated by the DEN2-induced cytokine. 
Replication of the virus in the brain is the additional 
mechanism in i.e. inoculated mice. 
In human cases of dengue the presentation which 
suggests CNS involvement is severe headache, halluci- 
nations, depression and grief. Rarely, encephalitic signs 
and symptoms are also seen but DEN could be isolated 
only from blood and not from the brain tissue or CSF 
(Sarkar et al., 1969; Myers et al., 1969; reviewed by 
Sumarmo et al., 1981). Pathological studies have shown 
frequent cerebral oedema, rarely haemorrhage but no 
evidence of encephalitis n such cases. A varying degree 
of cerebral oedema, even in benign dengue, may explain 
the origin of severe headaches. It is, therefore, likely that 
a cytokine, similar to that described here, may be one of 
the mechanisms of cerebral oedema in human cases of 
dengue. Clearly, more studies are needed to investigate 
this aspect in man. 
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